AbbVie, announced that it has completed its acquisition of ImmunoGen. With the completion of the acquisition, ImmunoGen is now part of AbbVie.
"Together with ImmunoGen,...
Iambic Therapeutics, a biotechnology company developing novel therapeutics using its AI-driven discovery platform, announced the appointment of oncologist and industry veteran Neil Josephson, M.D.,...
Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced the launch of its new analytical platform, LabZient. The standardized and automated platform...
Parse Biosciences, the premier provider of easy-to-use, scalable single-cell sequencing solutions, announced an agreement with INTEGRA Biosciences to combine Assist Plus with built-in Parse...
